Together we can help key policy makers at the federal and local levels better understand how their decisions on policy and legislation impact community oncology care. State and federal legislation can have a real impact on your bottom line and the financial viability of your organization, which is why it's so important that ACCC members bring their on-the-frontline perspectives to the legislative process.
On Wednesday, March 20, ACCC members representing 21 states and covering 150 districts headed to Capitol Hill to advocate on behalf of their cancer patients. Capitol Hill Day was the first opportunity for ACCC members to meet with the 116th Congress, a diverse legislative class featuring more than 100 newly elected Representatives and 10 Senators.
In nearly 70 scheduled meetings, participants advocated for oral parity (H.R.1730/S.741), clinical trial coverage for Medicaid enrollees with life-threatening conditions (H.R. 913), and discussed the rising cost of healthcare and drugs. Read the ACCC advocacy issue and advocacy briefs below:
During a luncheon address, Robyn Stacy-Humphries, MD, Radiation Oncologist and Patient Advocate, shared the compelling story of her battle with lymphoma and the importance of clinical trial access, having herself participated in a CAR T-cell therapy clinical trial.
Explore highlights from Capitol Hill Day 2019 here.
I appreciated all the energy around trying to move cancer to the forefront with people who can vote on policy.
— Gina Moon, CFO, Green Bay Oncology
[Congressional staff were] engaged, actively listening.
— Angela DeCillis, DNP, RN, NE-BC, Newark Beth Israel, RWJ Barnabus Health System
I think the level of support that ACCC provides is really great for newbies like me ... this has been a great opportunity to have a voice and be part of healthcare policy.
— Robin Hearne, MS, RN, The Outer Banks Hospital